Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rostaing

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2001
Treatment of hepatitis C virus infection after renal transplantation: new insightsL Rostaing
Nephrologie & Therapeutique|February 22, 2018
[Renal transplantation]L Rostaing
Nephrologie & Therapeutique|September 26, 2008
[Monitoring of calcineurin inhibitors induced-nephrotoxicity]N Kamar, L Rostaing
Current Opinion in Nephrology and Hypertension|November 18, 1998
Cyclosporin nephrotoxicity: pathophysiology and comparison with FK-506J L Ader, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Kidney International|March 4, 2006
Treatment of hepatitis C-virus-related glomerulonephritisN Kamar, L Rostaing, L Alric
Transplantation Proceedings|April 26, 2005
Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, prospective controlled studyG Mourad, L Rostaing, Ch Legendre, et al.
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patientsN Kamar, C Mengelle, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2007
Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney-transplant patientsN Kamar, K Sandres-Sauné, L Rostaing
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2001
Treatment of hepatitis C virus infection after renal transplantation: new insightsL Rostaing
Nephrologie & Therapeutique|February 22, 2018
[Renal transplantation]L Rostaing
Nephrologie & Therapeutique|September 26, 2008
[Monitoring of calcineurin inhibitors induced-nephrotoxicity]N Kamar, L Rostaing
Current Opinion in Nephrology and Hypertension|November 18, 1998
Cyclosporin nephrotoxicity: pathophysiology and comparison with FK-506J L Ader, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Kidney International|March 4, 2006
Treatment of hepatitis C-virus-related glomerulonephritisN Kamar, L Rostaing, L Alric
Transplantation Proceedings|April 26, 2005
Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, prospective controlled studyG Mourad, L Rostaing, Ch Legendre, et al.
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patientsN Kamar, C Mengelle, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2007
Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney-transplant patientsN Kamar, K Sandres-Sauné, L Rostaing
Pageof 21